Imr+e Corpon
Seattle, WA, 98109
DUNS:
# of Employees: N/A
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Award Charts
Award Listing
-
Record 1 TO 5
-
A SERIES OF FUCOSYLATED GLYCOSPHINGOLIPIDS WITH THE ""X'' DETERMINANT (GAL 1 4FUC 1 3GLCNAC) HAVE BEEN SHOWN TO ACCUMULATE IN HUMAN COLONIC AND LIVER ADENOCARCINOMA AND ARE VIRTUALLY ABSENT IN NORMAL COLONIC MUCOSA AND NORMAL LIVER TISSUE.
Amount: $50,000.00A SERIES OF FUCOSYLATED GLYCOSPHINGOLIPIDS WITH THE ""X'' DETERMINANT (GAL 1 4FUC 1 3GLCNAC) HAVE BEEN SHOWN TO ACCUMULATE IN HUMAN COLONIC AND LIVER ADENOCARCINOMA AND ARE VIRTUALLY ABSENT IN NORMAL ...
SBIRPhase I1985Department of Health and Human Services -
EASIER TO CONJUGATE TO ANTIBODIES WITH HIGHER REPRODUCIBILITY.
Amount: $50,000.00EASIER TO CONJUGATE TO ANTIBODIES WITH HIGHER REPRODUCIBILITY.THE AIM OF THIS RESEARCH IS TO ISOLATE AND CHARACTERIZE ANTIGENS IN CIRCULATING IMMUNE COMPLEXES (CIC) FROM PATIENTS WITH ACQUIRED IMMUNOD ...
SBIRPhase I1985Department of Health and Human Services -
SEVERAL RECENT REPORTS SUGGEST THAT EXTRACORPOREAL PERFUSION OF TUMOR BEARING PLASMA OVER PROTEIN A CONTAINING SUBSTRATES CAN RESULT IN OBJECTIVE TUMOR REGRESSION IN THE HOST.
Amount: $45,720.00SEVERAL RECENT REPORTS SUGGEST THAT EXTRACORPOREAL PERFUSION OF TUMOR BEARING PLASMA OVER PROTEIN A CONTAINING SUBSTRATES CAN RESULT IN OBJECTIVE TUMOR REGRESSION IN THE HOST. IN THE PRESENT INVESTIGA ...
SBIRPhase I1984Department of Health and Human Services -
WE HAVE REPORTED THAT EXTRACORPOREAL IMMUNOADSORPTION TO REMOVE CIRCULATING IMMUNE COMPLEXES (CIC) AND IGG RESULTS IN COMPLETE REGRESSION OF FELINE LYMPHOSARCOMA, CLEARANCE OF PERSISTANT FELINE LEUKEMIA VIRUS INFECTION AND HISTOLOGIC CHANGES ASSOCIATED
Amount: $50,000.00WE HAVE REPORTED THAT EXTRACORPOREAL IMMUNOADSORPTION TO REMOVE CIRCULATING IMMUNE COMPLEXES (CIC) AND IGG RESULTS IN COMPLETE REGRESSION OF FELINE LYMPHOSARCOMA, CLEARANCE OF PERSISTANT FELINE LEUKEM ...
SBIRPhase I1984Department of Health and Human Services -
THE OBJECTIVE OF THE PROPOSED RESEARCH IS TO DEVELOP AN IMMUNOLOGICALLY SPECIFIC ADSORBENT FOR USE IN EXTRACORPOREALSYSTEMS TO REMOVE IMMUNOREACTIVE IGM FROM THE SERUM OF PATIENTS FOR PRIMARY BILIARY CIRRHOSIS (PBC).
Amount: $26,704.00THE OBJECTIVE OF THE PROPOSED RESEARCH IS TO DEVELOP AN IMMUNOLOGICALLY SPECIFIC ADSORBENT FOR USE IN EXTRACORPOREALSYSTEMS TO REMOVE IMMUNOREACTIVE IGM FROM THE SERUM OF PATIENTS FOR PRIMARY BILIARY ...
SBIRPhase I1983Department of Health and Human Services
